Inotuzumab ozogamicin
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Inotuzumab Ozogamicin (coding:ncit:C71542)
RxNorm: inotuzumab ozogamicin (coding:rxcui:1942950, coding:omop:794068)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (2) | CD22 + | Acute Lymphoblastic Leukemia | Inotuzumab ozogamicin | |
| EMA (2) | CD22 +, not BCR::ABL1 | Acute Lymphoblastic Leukemia | Inotuzumab ozogamicin |